Genetic Signatures Ltd
Genetic Signatures Limited operates as a molecular diagnostic company in Australia, the Asia Pacific, Europe, the Middle East, Asia, and the Americas. It offers enteric bacteria, Enteroaggregative E.coli aggR and aaiC, enteric viral, enteric protozoan, enteric protozoan extended, enteric microsporidia, respiratory pathogen, SARS-CoV-2, extended respiratory, atypical respiratory, Measles, Mumps, a… Read more
Genetic Signatures Ltd (GSS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: -0.185x
Based on the latest financial reports, Genetic Signatures Ltd (GSS) has a cash flow conversion efficiency ratio of -0.185x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-9.25 Million) by net assets (AU$50.09 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Genetic Signatures Ltd - Cash Flow Conversion Efficiency Trend (2013–2025)
This chart illustrates how Genetic Signatures Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Genetic Signatures Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Genetic Signatures Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Christiani & Nielsen (Thai) Public Company Limited
BK:CNT
|
0.210x |
|
Bangkok Genomics Innovation Pcl
BK:BKGI
|
-0.002x |
|
CASH Financial Services Group Limited
F:CFN0
|
N/A |
|
FORSEE POWER(PROM.)EO-10
F:4OY
|
N/A |
|
Green World Hotels Co., Ltd.
TWO:8077
|
0.273x |
|
Pion Group AB Series B
ST:PION-B
|
-0.103x |
|
Zeo Energy Corp
NASDAQ:ZEO
|
-0.143x |
|
Laon People Inc.
KQ:300120
|
-1.020x |
Annual Cash Flow Conversion Efficiency for Genetic Signatures Ltd (2013–2025)
The table below shows the annual cash flow conversion efficiency of Genetic Signatures Ltd from 2013 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | AU$50.09 Million | AU$-12.29 Million | -0.245x | -48.12% |
| 2024-06-30 | AU$61.10 Million | AU$-10.12 Million | -0.166x | +42.92% |
| 2023-06-30 | AU$42.91 Million | AU$-12.45 Million | -0.290x | -262.15% |
| 2022-06-30 | AU$54.80 Million | AU$9.81 Million | 0.179x | +110.46% |
| 2021-06-30 | AU$49.34 Million | AU$4.20 Million | 0.085x | +141.13% |
| 2020-06-30 | AU$45.93 Million | AU$-9.49 Million | -0.207x | +3.71% |
| 2019-06-30 | AU$10.57 Million | AU$-2.27 Million | -0.215x | +22.12% |
| 2018-06-30 | AU$13.40 Million | AU$-3.69 Million | -0.276x | -76.69% |
| 2017-06-30 | AU$16.49 Million | AU$-2.57 Million | -0.156x | +71.62% |
| 2016-06-30 | AU$4.68 Million | AU$-2.57 Million | -0.550x | -38.78% |
| 2015-06-30 | AU$7.06 Million | AU$-2.80 Million | -0.396x | -372.97% |
| 2014-06-30 | AU$16.18 Million | AU$-1.35 Million | -0.084x | -123.40% |
| 2013-06-30 | AU$-3.32 Million | AU$-1.19 Million | 0.358x | -- |